Strategic Resale Alliance with Cardinal IP

Tekcapital

28/04/2026 07:00

RNS Number : 0764C

GenIP PLC

28 April 2026

 

 

 

28 April 2026

 

GenIP Plc

("GenIP" or the "Company")

 

Strategic Resale Alliance with Cardinal Intellectual Property

GenIP Plc (AIM: GNIP), a technology consultancy providing AI-driven services to help research organisations and corporations commercialise their innovations, announces a strategic alliance with  Cardinal Intellectual Property, Inc. ("Cardinal IP"), the leading U.S. provider of patent searching, managed docketing, AI patent drafting, AI amendment drafting, IP consulting, and IP annuity and renewal payment services, giving GenIP accelerated access to the US corporate market and a high-credibility distribution channel for its AI-enabled tools.

Highlights

·    The Alliance brings together GenIP's proprietary AI-driven analytics platform with Cardinal IP's industry leading professional services.

·    Cardinal IP is the premier IP services firm in the United States with deep operational scale and long standing client relationships, selected by the US Patent and Trademark Office (USPTO) to perform Patent Cooperation Treaty search services, and serves Fortune 500 corporations, government agencies and leading law firms.

·    The Alliance establishes a reciprocal sale relationship where both parties sell each others' products and services to their clients. This will expand the range of services each company can offer, establishing high margin, recurring service channels for both companies.

·    The Board considers this Alliance a material step in broadening GenIP's commercial footprint, given Cardinal IP's established position across major US corporate and legal innovation ecosystems.

Market Opportunity

The global IP services market exceeds $25bn annually (World Intellectual Property Organization), driven by rising patent filings, litigation activity, and sustained innovation investment.¹ Within this, the AI-enabled IP services segment is projected to exceed $8bn by 2030, with patent drafting and analytics among the fastest-growing subsegments.²

This Alliance creates a significant opportunity for GenIP to access the corporate and enterprise market. Global corporate R&D expenditure reached a historic high in 2024³ generating continuous and recurring demand for IP protection, portfolio management, and commercialisation support through the search, valuation, and analytics services this Alliance is structured to deliver. Cardinal IP's established Fortune 500 and law firm relationships provide GenIP with a direct distribution route into this segment at a scale its existing channels do not reach. GenIP's international network across 25+ countries extends the Alliance's addressable market beyond the United States.

Strategic Rationale

Few IP service providers combine the traditional IP operations at scale (Cardinal IP) with AI-driven analytics and automation (GenIP). This creates a differentiated, defensible market position in a sector that is beginning to adopt AI at scale.

The reciprocal fee structure provides a clear commercial pathway for both companies to generate incremental revenue from existing client relationships.

For GenIP

Revenue and margin acceleration: Cardinal IP provides a pipeline for subscription and repeat use AI services

Access to a large client base: GenIP's AI tools gain accelerated distribution into Cardinal IP's long-standing accounts

Credibility: Cardinal IP's established reputation strengthens GenIP's standing with corporations, law firms and research institutes

Scalability: Supports GenIP's transition toward a recurring revenue model, consistent with its platform growth strategy

Taken together, these factors strengthen GenIP's ability to participate in higher-value segments of the global IP services market using its existing operating model.

For Cardinal IP

International distribution: Access to GenIP's client network across 25+ countries at no capital cost, extending Cardinal IP's reach beyond its core US market

Expanded offering: GenIP's commercialisation analytics complement Cardinal IP's IP protection services across the full innovation lifecycle

New revenue streams: Incremental revenue from AI-assisted analytics at low marginal cost, without additional headcount

Melissa Cruz, CEO of GenIP, commented:

"This Alliance with Cardinal IP gives GenIP a credible distribution route into the corporate enterprise segment, the largest and most recurring part of the global IP services market. The fee structure is commercially grounded, with fees reaching up to 30% on AI-enabled drafting services, and the performance incentive built into the agreement ensures both parties are motivated to convert introductions into revenue. We have designated commercial teams on both sides and a clear go-to-market approach, and we look forward to adding value to both organisations and positioning GenIP at the forefront of the global IP services industry."

Nathan Frederick, Chief Operating Officer, Cardinal Intellectual Property, commented:

"Cardinal IP is strengthening its global presence through this new strategic alliance with GenIP. This collaboration allows us to access new international markets and deliver our top-tier IP services to a broader customer base. By combining Cardinal's industry-leading expertise with GenIP's innovative reach, we are set to drive accelerated sales growth and provide a wider array of services to a global audience."

About Cardinal Intellectual Property

Cardinal IP is the leading intellectual property services firm in the United States, serving Fortune 500 corporations, major law firms, and government agencies. Cardinal IP has been selected by the USPTO to perform Patent Cooperation Treaty search services. Further information: https://cardinal-ip.com

¹ WIPO, World Intellectual Property Indicators, 2023 ² Fortune Business Insights, AI in Legal Market, 2024 ³ WIPO, Global Innovation Index 2025, September 2025 ⁴ Parola Analytics, 2024 USPTO Patent Roundup

 

 

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc
Melissa Cruz, CEO
Via Redchurch Communications
Beaumont Cornish Limited (Nominated Adviser)
Roland Cornish / Asia Szusciak / Andrew Price
Tel: +44 (0) 20 7628 3396
AlbR Capital Limited (Broker)
Colin Rowbury
Jon Belliss
Tel: +44 (0)20 7399 9427
cr@albrcapital.com
Jb@albrcapital.com
Redchurch Communications (Financial PR)
John Casey
genip@weareredchurch.com

 

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

Notes to Editors

 

About GenIP

 

GenIP is a next-generation business      at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

 

Service Offerings

 

GenIP operates through two synergistic service lines:

 

 

Service
Description
Value Proposition
Invention Intelligence Product Suite
AI-powered market intelligence reports assessing the commercial potential of emerging technologies
Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy
Talent and Executive Search Services
Executive search platform using machine learning and NLP to match innovation-driven organisations with commercialisation-ready leadership
De-risks scaling by aligning technical vision with proven executive capability

 

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

 

Vision & Strategy

 

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

 

●    Organic Expansion

Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

●    Service Deepening

Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

●    Strategic Acquisitions

Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
UPDUBSORNSUSUAR